Overactive Bladder
Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom
October 7, 2015
Validation of the lower urinary tract symptom score
October 6, 2015
Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome.
October 6, 2015
Real-World Patterns of Care for the Overactive Bladder (OAB) Syndrome in the United States
October 6, 2015
Impact of childhood and recent traumatic events on the clinical presentation of overactive bladder
September 29, 2015
Postmenopausal overactive bladder
September 22, 2015
Is pretreatment cystometry important in predicting response to mirabegron in women with overactive bladder symptoms?
September 8, 2015
Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report
September 7, 2015
Assessment of overactive bladder in women antidepressant users
September 3, 2015
Neurochemical and neuroendocrine correlates of overactive bladder at first demyelinating episode
September 2, 2015
Early investigational β3 adreno-receptor agonists for the management of the overactive bladder syndrome.
September 1, 2015
[Effect of the type of urinary incontinence on the quality of life of patients in the public healthcare system in Southeastern Brazil]
September 1, 2015
New evidence in the treatment of overactive bladder
September 1, 2015
Reliability and validity of urinary nerve growth factor measurement in women with lower urinary tract symptoms
August 19, 2015